Meinntech has been chosen as a post-market medical device clinical trial project of Korea Health Industry Development Institute to verify the safety, efficacy, and economic efficiency of a cylinder pump, Anyfusion V-100 through clinical trials at the clinical support center for Medical Devices and Clinical Trial at Yonsei University Severance Hospital.

Over the past 10 years, there has been no clinical study of drug infusion with infusion pump. Only there have been clinical trials and papers on insulin for last 10 years.

As mentioned above, the reason for not publishing through the clinical trials with drug infusion pump is that there is no factor that could have a meaningful effect on the medication from the existing drug injection pump. Anyfusion, the next generation medicine injection pump, in order to solve the above-mentioned medical accidents, the free flow, regurgitation, inadvertent bolus, accidental bolus, and siphoning phenomenon, which could only be caused by the structural limitations of the cylinder pump; the reference and evidence proved through clinical trials at Seoul National University, Yonsei University and Gachon Gil Hospital, which are the best universities in Korea, will give meaning an value in domestic and overseas clinical fields.

The three hospitals will be conduction clinical trials targeting different clinical fields. The clinical results will be published in the International Journal and the Korean Journal, and will be reported at the relevant conferences. Anyfusion, the next generation pharmaceutical infusion pump, will change the paradigm of the drug injection market medically, academically, and clinically in ways to luxury; thus we aim to cultivate 80% of global drug injection pump market with more than 500 million dollar annual sales, as most of the original technology products maintain a market share status of 80% of the relevant market.

Furthermore, we would like to develop various application products such as infusion pump for blood, micro medical factor detect, desensitization for hypersensitivity reactions related to chemotheraphy, etc. as the original technology of cylinder pump and develop to become Korean leading medical device.

Thank you for all your efforts.